Search for: "ACTAVIS PHARMA, INC."
Results 61 - 80
of 127
Sorted by Relevance
|
Sort by Date
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
20 Feb 2009, 1:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
7 Nov 2008, 3:42 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
16 Nov 2012, 2:30 am
The defendants in their case include Watson Laboratories Inc., Actavis Elizabeth LLC and Pliva Inc., manufacturers of the generic equivalent of Reglan, as well as Schwartz Pharma. [read post]
10 Jun 2010, 3:58 am
Actavis Inc. et al. [read post]
1 Dec 2010, 12:15 am
Abraxis Bioscience, Inc. v. [read post]
8 May 2009, 8:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
3 Aug 2011, 3:31 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
21 Jul 2010, 1:05 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
14 Oct 2009, 7:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
13 May 2010, 4:58 pm
Pharma Change ApS - Actavis A/S entered as independent party (EPLAW) Metvixia (Methyl aminolevulinate) - US: CAFC upholds patent term extensions in Levaquin and Metvixia cases: Ortho-McNeil and Daiichi Sankyo v. [read post]
27 Mar 2009, 8:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
22 Mar 2011, 4:21 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
19 Dec 2008, 1:00 pm
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
21 Mar 2015, 6:26 am
Actavis plc (NYSE:ACT), No. 1:14-cv-00882 (D. [read post]
27 Jan 2010, 3:00 am
- ‘indirect consumer tax’ to fund UN public health initiatives (Afro-IP) Canada: Submissions on Canada-EU trade deal: Canadian Generic Pharma Assoc. wants IP out (Michael Geist) Canada: Intellectual property and agriculture – CDC Triffid seed story (ipblog.ca) EU: Records of the 1st, 2nd and 3rd expert meetings on SPCs (The SPC Blog) EU: Cooperation between Board of Appeal and National Court / acceleration of appeal proceedings: Human Genome Sciences v Eli Lilly (EPLAW)… [read post]
16 Dec 2009, 3:39 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
3 Aug 2009, 7:29 am
All responding defendants (Actavis, Inc.; Actavis-Elizabeth, L.L.C.; Barr Pharmaceuticals, Inc.; Baxter Healthcare Corp.; Duramed Pharmaceuticals, Inc.; Pliva, Inc.; Pliva USA, Inc.; Schwarz Pharma, Inc.; Teva Pharmaceuticals USA, Inc.; and Wyeth) opposed centralization, as did one Plaintiff from Vermont. [read post]
6 Apr 2011, 12:18 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
